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Abstract
Background: Concomitant leprosy and tuberculosis is reported infrequently. Literature suggests
that the infrequent occurrence of both leprosy and tuberculosis is based on the transmission
dynamics of both the infections.
Case presentation: Two cases of pulmonary tuberculosis diagnosed in patients being treated
with glucocorticoids for complications of leprosy are reported.
Conclusion: Clinicians should recognize corticosteroid treated leprosy patients as a population
likely to develop concomitant tuberculosis.
Background
There have been sporadic reports of co-existence of tuber-
culosis and leprosy in the same patients [1-4]. These
reports suggest that it is important to identify these cases
to avoid monotherapy of tuberculosis. One study has also
reported that tuberculosis may occur through the spec-
trum of leprosy [5]. We report two cases of leprosy who
were on treatment for related complications and were also




A 65-year-old non-hypertensive, non-diabetic man pre-
sented with history of left sided chest pain associated with
productive cough and breathlessness for seven days. There
was no history of fever, haemoptysis and exertional
increase in breathlessness. The patient was referred to our
teaching hospital from Green Pastures Hospital (GPH), a
tertiary care referral centre for leprosy. The patient was
treated for leprosy with WHO multidrug therapy for
multibacillary leprosy. The patient was currently on treat-
ment for ulnar neuritis with prednisolone 30 mg once a
day for last three months. There was no past history of
tuberculosis as per GPH records or information provided
by the patient.
Clinical examination revealed numerous hypopigmented
skin lesions varying in size from 2 to 10 centimeters over
the trunk. The left ulnar nerve was thickened. There was
dullness and decreased breath sounds in the left infras-
capular and axillary areas.
The laboratory investigations revealed hemoglobin: 14.4
mg/dl; total leukocyte count: 19.5×103; erythrocyte sedi-
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mentation rate: 60 mm at the end of first hour; serum cre-
atinine: 1.4 mg/dl; and random blood sugar: 91 mg/dl.
One out of three sputum samples tested was positive for
acid fast bacilli and the chest radiograph showed locu-
lated pleural effusion suggesting long standing pleural
collection in left hemi thorax with infiltrations bilaterally,
more on left side.
A diagnosis of borderline leprosy with concomitant pul-
monary tuberculosis was made. The patient was referred
to DOTS clinic of our teaching hospital and started on cat-
egory-I treatment according to the guidelines of national
tuberculosis programme of Nepal. The oral prednisolone
was subsequently tapered and stopped. The patient's gen-
eral condition improved and was on regular follow up.
Patient 2
A 50-year-old non-diabetic, non-hypertensive man who
had completed treatment for lepromatous leprosy two
years back, was admitted at Green Pastures Hospital for
type-2 lepra reaction (erythema nodosum leprosum).
There was a past history of lepra reactions for which he
underwent treatment. Currently the patient was again
being treated for the same with prednisolone 30 mg once
daily, thalidomide 100 mg twice daily and clofazimine 50
mg once daily. However, information about initial screen-
ing of tuberculosis was not available.
The patient was referred to our teaching hospital with
complaints of fever, productive cough and dyspnoea of
three months duration. The patient also complained of
pain and distension of abdomen and decreased appetite
for three months.
Clinical examination revealed tense abdomen with shift-
ing dullness, respiratory system with bilateral crackles
with bronchial breath sounds predominantly in the left
infra clavicular area, and skin showed no active lesions of
erythema nodosum leprosum. The laboratory investiga-
tions revealed hemoglobin: 11.8 mg/dl; total leukocyte
count: 5900/mm3; erythrocyte sedimentation rate: 110
mm in first hour; random blood sugar: 109 mg/dl; serum
electrolytes, sodium: 135 meq/L and potassium: 3.2 meq/
L.
Two out of three sputum samples were positive for acid
fast bacilli. Chest radiograph showed multiple heteroge-
neous opacities in bilateral lung fields and a cavitary
lesion in left upper zone. A diagnosis of pulmonary tuber-
culosis and provisional diagnosis of peritoneal tuberculo-
sis were made.
Dermatologist's opinion was sought for the lepra reaction.
The patient was advised to stop prednisolone as no active
lesions persisted. He was subsequently referred to DOTS
clinic and was started on category-I treatment.
Discussion
Literature suggests that a cross-immunity exists between
tuberculosis and leprosy. Chaussinad was the first to
observe that in several different settings the prevalence of
leprosy was inversely related to that of tuberculosis. There-
fore, it may be unusual to come across co-existence of
tuberculosis and leprosy. A study from South Africa
reported that there was an increased incidence of pulmo-
nary tuberculosis among leprosy patients but not vice
versa [6]. Researchers have also suggested that individuals
acquired protection against leprosy by previous infection/
exposure to tuberculosis. Therefore, it is believed that
BCG vaccine may give some protection against leprosy
[7]. This theory of cross-immunity between tuberculosis
and leprosy lead to the hypotheses for disappearance of
leprosy from Western Europe before the advent of chem-
otherapy [8]. A study based on examination of DNA by
PCR technique investigated the relation between tubercu-
losis and leprosy among archaeological samples.
Researchers found the evidence for co-existence of tuber-
culosis and leprosy [9]. This supports an earlier report that
tuberculosis can occur throughout the spectrum of leprosy
[5]. The research on the archaeological samples refutes the
hypotheses about the existence of cross-immunity
between tuberculosis and leprosy and suggested an alter-
native explanation for decline of leprosy from Western
Europe. The authors suggested that the immunological
changes seen in multi-bacillary leprosy together with soci-
oeconomic impact of the disease may have lead to
increased mortality due to tuberculosis which resulted in
the decline of leprosy in Western Europe [9]. Despite this
long history of epidemiological, clinical and microbio-
logical evidences the exact relationship between tubercu-
losis and leprosy still remains unclear.
Nepal is one of the five countries where leprosy is
endemic and also a high burden country for tuberculosis.
In the earlier reports of concomitant occurrence of leprosy
and tuberculosis, leprosy was preceded by tuberculosis
which is similar to our case presentations [1-3]. This is
unlike a case presentation reported from the USA in which
a Filipino patient who was undergoing treatment for pul-
monary tuberculosis when he was diagnosed to have lep-
rosy also [4]. It is important to note that in our case
presentations both the patients were treated for leprosy in
the past and had developed complications of leprosy. In
our case presentations, concomitant occurrence of tuber-
culosis may have been a result of steroid treatment for
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Conclusion
Treatment with steroid may have decreased the immunity
and predisposed the patients to reactivation of tuberculo-
sis. One study has reported that the patients treated with
glucocorticoids are at an increased risk of pulmonary
tuberculosis [10]. One of our two cases presented with
symptoms suggestive of tuberculosis which were of three
months duration, and the other patient had a loculated
pleural effusion. It was not sure if this was a patient delay
or treating physician's delay (health system delay) in our
case presentations. Therefore, it becomes imperative for
physicians treating leprosy complications with steroids to
have a high degree of suspicion to diagnose pulmonary
tuberculosis. This infrequent concurrence may not be
expected since it is generally believed that cross-immunity
exists between TB and leprosy. This should be cautioned
in countries like Nepal where leprosy and tuberculosis
both are endemic. It is important to screen the patients for
TB before initiating long term steroid treatment. Facilities
for diagnosis and treatment of both conditions should be
made available in the same set up as it may optimize the
use of resources. Physicians should recognize that the lep-
rosy patients treated with glucocorticoid may develop
tuberculosis. Physicians should screen the patients for TB
before initiating long term steroid treatment and under-
take necessary periodical investigations to diagnose the
concomitant condition.
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